Pricing Log in Create free account

Quince Therapeutics, Inc. (IRLA) vs NanoViricides, Inc. (NNVC)

Quince Therapeutics, Inc. and NanoViricides, Inc. are both Biotechnology companies. Quince Therapeutics, Inc. and NanoViricides, Inc. are of similar size ($35.0M and $33.8M). Across the 8 metrics below, Quince Therapeutics, Inc. leads on 6 and NanoViricides, Inc. on 2.

Valuation

Metric IRLA NNVC Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 3.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (442.37%) (28.89%) (33.15%)
Free cash flow yield (23.96%) (27.93%) (25.50%)

Profitability

Metric IRLA NNVC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 784.09% (101.46%) (56.36%)
Return on assets (76.68%) (87.91%) (48.04%)
Return on invested capital 0.00% (88.16%) 0.00%

Growth

Metric IRLA NNVC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (28.24%) 35.38% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRLA NNVC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.52 2.66 4.72
Net debt to EBITDA 0.00 0.36 0.96

Dividend

Metric IRLA NNVC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IRLA NNVC Biotechnology median
Market cap 33.79m 34.97m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack